Amantadine
Pk-Merz-Schoeller · ATC code N04BB01
Also known as: Amantadin · Brand names: Pk-Merz-Schoeller, Amantadin Ratiopharm, Amantadin Stada, Pk-Merz, Neomidantan
- Key facts
- Active substance
- Amantadine
- Drug class
- Dopaminergic
- ATC code
- N04BB01
- Authorisation
- authorised nationally; no central EU authorisation
- Information as of
- 2026-10-27
Key facts
Amantadine is an antiviral and dopaminergic agent. Per the US label, it is used for prophylaxis and treatment of influenza A and for parkinsonism and drug-induced extrapyramidal reactions.
What it is used for
- Chemoprophylaxis against signs and symptoms of influenza A virus infection
- Treatment of uncomplicated respiratory tract illness caused by influenza A, especially when given early
- Parkinsonism
- Drug-induced extrapyramidal reactions
Dosing
- Influenza A, adults: 200 mg daily as a single dose, or split as 100 mg twice a day
- Persons 65 years of age or older: 100 mg daily
- Children 9 to 12 years: 200 mg daily given as 100 mg twice a day; younger children receive a weight-based dose with a daily maximum
- Prophylaxis: at least 10 days after a known exposure; treatment should start as soon as possible, preferably within 24 to 48 hours of symptom onset
- Dose may need reduction in congestive heart failure, peripheral edema, orthostatic hypotension or impaired renal function
- Parkinsonism and renal-impairment dosing: see the full prescribing information
Contraindications
- Known hypersensitivity to amantadine hydrochloride or any other ingredient
Important warnings
- Deaths reported from overdose; toxicity may be cardiac, respiratory, renal or CNS
- Deaths from drug accumulation in patients with renal impairment given higher than recommended doses
- Suicide attempts have been reported
- Dose caution in congestive heart failure, peripheral edema and orthostatic hypotension
Side effects
- Most frequent (5 to 10%): nausea, dizziness (lightheadedness), insomnia
- Less frequent: depression, anxiety, hallucinations, confusion, dry mouth, constipation, livedo reticularis, peripheral edema, orthostatic hypotension
- Infrequent: congestive heart failure, psychosis, urinary retention, visual disturbance including corneal opacity
- Rare: convulsion, leukopenia, neutropenia, suicidal ideation and suicide
Summary of the official product information, written with AI (Claude, Anthropic) on 2026-10-28. Every number was checked automatically against the original text. Not reviewed by a physician – the full official text is authoritative.
Common questions – ask Medelix
For patients
Patient information (US)
This product has no separate US patient information.
Authorisation and brand names by country
Medicines with exactly this active-substance composition, as listed in the national registers – alphabetical and without ranking. Whether a product is currently available is not shown here.
Austria
- Pk-Merz-SchoellerMerz Pharma Austria Gmbh · 2 register entries
Source: EMA – Article 57 product data (EU/EEA), as of 2026-10-28
Germany
- Amantadin RatiopharmRatiopharm Gmbh · 1 register entry
- Amantadin StadaStadapharm Gmbh · 1 register entry
- Pk-MerzMerz Pharmaceuticals Gmbh · 2 register entries
Source: EMA – Article 57 product data (EU/EEA), as of 2026-10-28
Turkey
- NeomidantanOLPHA İLAÇ VE TIBBİ ÜRÜNLER SAN. VE TİC. LTD. ŞTİ. · 1 register entry
- Pk-MerzASSOS İLAÇ KİMYA GIDA ÜRÜNLERİ ÜRETİM VE TİC. A.Ş. · 4 register entries
Source: TİTCK – Ruhsatlı Beşeri Tıbbi Ürünler Listesi, as of 2026-10-16
Brand names in 23 more European countries
- Bulgaria
- Пк-Мерц
- Croatia
- Pk-Merz
- Czechia
- Pk-Merz, Viregyt-K
- Denmark
- Amypha, Dinetrel, Parkadin
- Estonia
- Amantadin Ratiopharm
- Finland
- Amypha, Parkadin
- France
- Mantadix
- Greece
- Symmetrel
- Hungary
- Pk-Merz, Viregyt
- Ireland
- Amantadine Hydrochloride Renata
- Italy
- Mantadan
- Latvia
- Neomidantan, Pk-Merz
- Lithuania
- Amantadin Ratiopharm, Pk-Merz
- Luxembourg
- Pk-Merz®
- Malta
- Amantadine Hydrochloride Renata, Parkadina
- Netherlands
- Amantadine Hcl Renata, Amypha, Symmetrel
- Norway
- Amypha, Dinetrel, Parkadin
- Poland
- Amantix, Viregyt-K
- Portugal
- Amantadina Renata, Amantadine Hydrochloride Renata Pharmaceuticals (Ireland), Parkadina
- Romania
- Viregyt-K
- Slovakia
- Pk-Merz, Viregyt-K
- Spain
- Amantadine Level
- Sweden
- Amypha, Dinetrel, Parkadin
EMA – Article 57 product data (EU/EEA), 2026-10-28
Medelix receives no money from pharmaceutical companies. Brand names are listed alphabetically and without ranking.
Another question about this substance?
Medelix answers clinical questions from guidelines, studies and product information – every claim with its source.
Sources
- U.S. Food and Drug Administration. amantadine hydrochloride (AvKARE) – Prescribing Information, 2026-06-17. DailyMed (NLM), 2026-10-27. https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=547904f3-84a3-1ccb-e063-6294a90a6fb6
- EMA – Article 57 product data (EU/EEA), 2026-10-28. https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/data-medicines-iso-idmp-standards-post-authorisation/public-data-article-57-database
- EMA – Article 57 product data (EU/EEA), 2026-10-28. https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/data-medicines-iso-idmp-standards-post-authorisation/public-data-article-57-database
- TİTCK – Ruhsatlı Beşeri Tıbbi Ürünler Listesi, 2026-10-16. https://www.titck.gov.tr/dinamikmodul/85
- Wikidata (CC0): ATC N04BB.
Editorial: Medelix editorial team · last updated 2026-10-27 · How these pages are made · Report an error
Source: U.S. Food and Drug Administration (FDA), prescribing information, via DailyMed (NLM); public domain. Not advertising, not a treatment recommendation. For questions about your own treatment, ask your doctor or pharmacist.